Background: Basic National Institute of Health (NIH) and sensitive antihuman globulin (AHG) methods are widely used for T-cell complement-dependent cytotoxicity crossmatch (XM) tests. Whereas NIH-negative, AHG-positive (NIH − /AHG ＋ ) results are caused by weak antibodies, NIH ＋ /AHG − results are usually due to autoantibodies. We found that solid organ transplantation candidates with NIH ＋ /AHG − XM results are repeatedly excluded from allocation of deceased donor organs by the Korean Network for Organ Sharing (KONOS) allocation system. Here, we attempted to demonstrate that these patients do not have donor-specific HLA antibodies (DSAs). Methods: Sera showing NIH ＋ /AHG − results in the analysis of 1,668 KONOS T-cell XM tests were screened for panel reactive antibody (PRA) using a Luminex test. For screen-positive samples, antibody identification was conducted using a Luminex single antigen assay and the presence or absence of class I DSAs was determined. For positive controls, 42 KONOS XM tests showing probable true-positive (NIH − /AHG ＋ or NIH ＋ /AHG ＋ ) results were reviewed for PRA results based on electronic medical records and the presence or absence of DSAs was determined. Results: NIH ＋ /AHG − results were observed in 1.3% (21/1,668) of KONOS XM tests analyzed. Most of these (18/21, 85.7%) were negative for PRA or DSAs. All probable true-positive cases were either positive for DSAs (24/42, 57.1%) or had high PRA (mean, 92% [range; 42%∼100%]), complicating accurate identification of antibody specificities. Conclusions: NIH ＋ /AHG − results are not rare (1.3%) in KONOS XM tests. Most of these results are not due to DSAs, and these patients should not be excluded from organ allocation.
INTRODUCTION
However, because IgM autoantibodies react with both patient's own lymphocytes and random donor lymphocytes(3), patients with these antibodies show positive cytotoxicity XM results with multiple donors, and they are repeatedly ex-cluded from organ allocation. The aims of the study were to prove that these patients do not have donor-specific HLA antibodies (DSAs) and to change the current organ allocation policy of the KONOS.
MATERIALS AND METHODS

Study population
The study population was from KONOS XMs performed at the Seoul National University Hospital between January 
HLA crossmatch tests
T-cell CDC XMs using standard NIH and AHG methods were performed as previously described (4 
RESULTS
Results of KONOS T-cell CDC XM tests
Results of KONOS T-cell CDC XM tests during the study period are shown in Table 1 . Fig 1) . 
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